208 related articles for article (PubMed ID: 17269668)
1. Alternatives to chromatographic separations.
Thömmes J; Etzel M
Biotechnol Prog; 2007; 23(1):42-5. PubMed ID: 17269668
[TBL] [Abstract][Full Text] [Related]
2. Bioseparation in antibody manufacturing: the good, the bad and the ugly.
Gottschalk U
Biotechnol Prog; 2008; 24(3):496-503. PubMed ID: 18442255
[TBL] [Abstract][Full Text] [Related]
3. Advances in primary recovery: centrifugation and membrane technology.
Roush DJ; Lu Y
Biotechnol Prog; 2008; 24(3):488-95. PubMed ID: 18410157
[TBL] [Abstract][Full Text] [Related]
4. Very large scale monoclonal antibody purification: the case for conventional unit operations.
Kelley B
Biotechnol Prog; 2007; 23(5):995-1008. PubMed ID: 17887772
[TBL] [Abstract][Full Text] [Related]
5. Membrane adsorbers as purification tools for monoclonal antibody purification.
Boi C
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 848(1):19-27. PubMed ID: 16996324
[TBL] [Abstract][Full Text] [Related]
6. Scale-up of monoclonal antibody purification processes.
Aldington S; Bonnerjea J
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 848(1):64-78. PubMed ID: 17224311
[TBL] [Abstract][Full Text] [Related]
7. Using precipitation by polyamines as an alternative to chromatographic separation in antibody purification processes.
Ma J; Hoang H; Myint T; Peram T; Fahrner R; Chou JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(9-10):798-806. PubMed ID: 20181538
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in large-scale production of monoclonal antibodies and related proteins.
Shukla AA; Thömmes J
Trends Biotechnol; 2010 May; 28(5):253-61. PubMed ID: 20304511
[TBL] [Abstract][Full Text] [Related]
9. State-of-the-art in downstream processing of monoclonal antibodies: process trends in design and validation.
Marichal-Gallardo PA; Alvarez MM
Biotechnol Prog; 2012 Jul; 28(4):899-916. PubMed ID: 22641473
[TBL] [Abstract][Full Text] [Related]
10. DNA spike studies for demonstrating improved clearance on chromatographic media.
Butler MD; Kluck B; Bentley T
J Chromatogr A; 2009 Oct; 1216(41):6938-45. PubMed ID: 19733359
[TBL] [Abstract][Full Text] [Related]
11. Process and economic evaluation for monoclonal antibody purification using a membrane-only process.
Varadaraju H; Schneiderman S; Zhang L; Fong H; Menkhaus TJ
Biotechnol Prog; 2011; 27(5):1297-305. PubMed ID: 21618725
[TBL] [Abstract][Full Text] [Related]
12. Performance of a new protein A affinity membrane for the primary recovery of antibodies.
Boi C; Dimartino S; Sarti GC
Biotechnol Prog; 2008; 24(3):640-7. PubMed ID: 18473438
[TBL] [Abstract][Full Text] [Related]
13. Decision-support software for the industrial-scale chromatographic purification of antibodies.
Chhatre S; Thillaivinayagalingam P; Francis R; Titchener-Hooker NJ; Newcombe AR; Keshavarz-Moore E
Biotechnol Prog; 2007; 23(4):888-94. PubMed ID: 17630695
[TBL] [Abstract][Full Text] [Related]
14. Parallel, high-throughput purification of recombinant antibodies for in vivo cell assays.
Bannister D; Wilson A; Prowse L; Walsh M; Holgate R; Jermutus L; Wilkinson T
Biotechnol Bioeng; 2006 Aug; 94(5):931-7. PubMed ID: 16570309
[TBL] [Abstract][Full Text] [Related]
15. Non-size-based membrane chromatographic separation and analysis of monoclonal antibody aggregates.
Wang L; Hale G; Ghosh R
Anal Chem; 2006 Oct; 78(19):6863-7. PubMed ID: 17007507
[TBL] [Abstract][Full Text] [Related]
16. Application of high-performance tangential flow filtration (HPTFF) to the purification of a human pharmaceutical antibody fragment expressed in Escherichia coli.
Lebreton B; Brown A; van Reis R
Biotechnol Bioeng; 2008 Aug; 100(5):964-74. PubMed ID: 18393314
[TBL] [Abstract][Full Text] [Related]
17. Paper-PEG-based membranes for hydrophobic interaction chromatography: purification of monoclonal antibody.
Yu D; Chen X; Pelton R; Ghosh R
Biotechnol Bioeng; 2008 Apr; 99(6):1434-42. PubMed ID: 17972326
[TBL] [Abstract][Full Text] [Related]
18. Scale-down of continuous filtration for rapid bioprocess design: Recovery and dewatering of protein precipitate suspensions.
Reynolds T; Boychyn M; Sanderson T; Bulmer M; More J; Hoare M
Biotechnol Bioeng; 2003 Aug; 83(4):454-64. PubMed ID: 12800139
[TBL] [Abstract][Full Text] [Related]
19. Separation of immunoglobulin G precipitate from contaminating proteins using microfiltration.
Neal G; Francis R; Shamlou PA; Keshavarz-Moore E
Biotechnol Appl Biochem; 2004 Apr; 39(Pt 2):241-8. PubMed ID: 15032745
[TBL] [Abstract][Full Text] [Related]
20. Implementation of advanced technologies in commercial monoclonal antibody production.
Zhou JX; Tressel T; Yang X; Seewoester T
Biotechnol J; 2008 Oct; 3(9-10):1185-200. PubMed ID: 18759247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
